Medicxi Launches Alys Pharmaceuticals in $100m Seed Funding
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
- Latest
- Trending
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
Virtual reality and augmented reality are redefining professional training and education, creating immersive and interactive learning experiences that enhance engagement ...
Unite Group and Newcastle University have formed a joint venture to develop 2,000 student beds, addressing the increasing demand for ...
A groundbreaking study reveals a new method to control terahertz waves, enhancing imaging and communication technology. This technique could revolutionize ...
The profits of oil companies, including BP, Shell, Chevron, ExxonMobil, and TotalEnergies, have skyrocketed during the Russia-Ukraine conflict, reaching $281 ...
HSBC CEO Noel Quinn is optimistic about strong 2023 earnings amid rising interest rates. However, challenges in China and Hong ...
Northern Kentucky University has appointed Chris Calvert as its new Vice President for Administration and Finance and Chief Financial Officer. ...
The candlelight vigil at Saint Augustine's University demonstrates support amid financial challenges and accreditation uncertainties. The university seeks to stabilize ...
Engineers at the University of Pennsylvania have developed a chip that uses light waves to improve the speed and efficiency ...
Adding narrative elements to VR exercise games increases the intensity of physical activity, according to a study. While gameplay duration ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.